ZLD 12.4% 39.0¢ zelira therapeutics limited

Ann: Zelira Presentation ASX Small and Mid-Cap Conference, page-30

  1. BI
    201 Posts.
    lightbulb Created with Sketch. 25
    There’s been a lot of fluff and disappointment along a very long journey. The US merger brought a lot of promised but so far have been poor to deliver. Still not convinced with that US team though. The next 3-6 months is make or break for this company IMHO. GLTAH
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.